-
-
-
-
-
-
-
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
-
-
-
-
-
-
-
Ligand Pharma (LGND) Introduces 2025 Guidance
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Verona Pharma (VRNA)
-
-
-
-
-
-
-
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Verona Pharma plc (VRNA) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
Verona Pharma plc (VRNA) Tops Q1 EPS by 8c
-
-
-
-
-
-
-
Verona Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

